Engene appoints lota s. zoth, cpa, as member of the board of directors

Boston and montreal , dec. 19, 2023 /prnewswire/ - engene holdings inc. ("engene," nasdaq: engn), a clinical-stage genetic medicines company whose lead program is in a pivotal study for bcg-unresponsive non-muscle invasive bladder cancer (nmibc), today announced the appointment of lota s. zoth, cpa, as a member of the board of directors and audit committee chair.
ENGN Ratings Summary
ENGN Quant Ranking